These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27771741)

  • 1. Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report.
    Owonikoko TK; Kumar M; Yang S; Kamphorst AO; Pillai RN; Akondy R; Nautiyal V; Chatwal MS; Book WM; Sahu A; Sica GL; Ahmed R; Ramalingam SS
    Cancer Immunol Immunother; 2017 Jan; 66(1):45-50. PubMed ID: 27771741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue.
    Aguirre LE; Guzman ME; Lopes G; Hurley J
    Oncologist; 2019 Mar; 24(3):394-401. PubMed ID: 30413665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Checkpoint Inhibitor-Induced Rejection of a Liver Allograft: A Combination of Acute T Cell-Mediated and Antibody-Mediated Rejection.
    Lee BT; Horwich BH; Chopra S; Ahearn A; Han HH
    Liver Transpl; 2019 Dec; 25(12):1845-1848. PubMed ID: 31408574
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor Regression and Allograft Rejection after Administration of Anti-PD-1.
    Lipson EJ; Bagnasco SM; Moore J; Jang S; Patel MJ; Zachary AA; Pardoll DM; Taube JM; Drake CG
    N Engl J Med; 2016 Mar; 374(9):896-8. PubMed ID: 26962927
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Allograft Rejection and Autoimmune Hemolytic Anemia After Anti-PD1 Therapy in a Kidney Transplanted Patient.
    Deltombe C; Garandeau C; Renaudin K; Hourmant M
    Transplantation; 2017 Sep; 101(9):e291. PubMed ID: 29633980
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.
    Ong M; Ibrahim AM; Bourassa-Blanchette S; Canil C; Fairhead T; Knoll G
    J Immunother Cancer; 2016; 4():64. PubMed ID: 27777773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral immunotherapy with anti-PD-1 and TLR9 agonist induces systemic antitumor immunity without accelerating rejection of cardiac allografts.
    Dang N; Waer M; Sprangers B; Lin Y
    Am J Transplant; 2021 Jan; 21(1):60-72. PubMed ID: 32506732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy.
    Boils CL; Aljadir DN; Cantafio AW
    Am J Transplant; 2016 Aug; 16(8):2496-7. PubMed ID: 26988410
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies.
    Azpilikueta A; Agorreta J; Labiano S; Pérez-Gracia JL; Sánchez-Paulete AR; Aznar MA; Ajona D; Gil-Bazo I; Larrayoz M; Teijeira A; Rodriguez-Ruiz ME; Pio R; Montuenga LM; Melero I
    J Thorac Oncol; 2016 Apr; 11(4):524-36. PubMed ID: 26845193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.
    Abdel-Wahab N; Safa H; Abudayyeh A; Johnson DH; Trinh VA; Zobniw CM; Lin H; Wong MK; Abdelrahim M; Gaber AO; Suarez-Almazor ME; Diab A
    J Immunother Cancer; 2019 Apr; 7(1):106. PubMed ID: 30992053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient.
    Herz S; Höfer T; Papapanagiotou M; Leyh JC; Meyenburg S; Schadendorf D; Ugurel S; Roesch A; Livingstone E; Schilling B; Franklin C
    Eur J Cancer; 2016 Nov; 67():66-72. PubMed ID: 27614165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
    Xia G; He J; Zhang Z; Leventhal JR
    Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney retransplantation after anti-programmed cell death-1 (PD-1)-related allograft rejection.
    Lipson EJ; Naqvi FF; Loss MJ; Schollenberger MD; Pardoll DM; Moore J; Brennan DC
    Am J Transplant; 2020 Aug; 20(8):2264-2268. PubMed ID: 32185872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of T-cell phenotype characterization in endomyocardial biopsy fragments from human cardiac allografts.
    Higuchi ML; de Assis RV; Sambiase NV; Reis MM; Kalil J; Bocchi E; Fiorelli A; Stolf N; Bellotti G; Pileggi F
    J Heart Lung Transplant; 1991; 10(2):235-42. PubMed ID: 1674430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pembrolizumab-induced severe rejection and graft intolerance syndrome resulting in renal allograft nephrectomy.
    Padala SA; Patel SK; Vakiti A; Patel N; Gani I; Kapoor R; Muhammad S
    J Oncol Pharm Pract; 2021 Mar; 27(2):470-476. PubMed ID: 32580640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection.
    Shi J; Luo F; Shi Q; Xu X; He X; Xia Y
    BMC Nephrol; 2015 Nov; 16():182. PubMed ID: 26525294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.